Elizabeth Juarez-Colunga
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 6 | 2024 | 138 | 1.320 |
Why?
| | Models, Statistical | 5 | 2026 | 671 | 0.880 |
Why?
| | Vigabatrin | 2 | 2022 | 19 | 0.830 |
Why?
| | Arthroplasty, Replacement, Knee | 5 | 2025 | 372 | 0.700 |
Why?
| | Isoantibodies | 1 | 2021 | 57 | 0.660 |
Why?
| | Pseudomonas Infections | 2 | 2022 | 230 | 0.640 |
Why?
| | Graft Rejection | 2 | 2021 | 518 | 0.640 |
Why?
| | Cystic Fibrosis | 5 | 2025 | 1160 | 0.610 |
Why?
| | Machine Learning | 2 | 2021 | 586 | 0.570 |
Why?
| | Disease Transmission, Infectious | 1 | 2019 | 69 | 0.560 |
Why?
| | Algorithms | 3 | 2025 | 1845 | 0.550 |
Why?
| | Vaccination Coverage | 1 | 2019 | 102 | 0.520 |
Why?
| | Behavior Therapy | 2 | 2019 | 294 | 0.490 |
Why?
| | Health Education | 1 | 2019 | 345 | 0.460 |
Why?
| | Longitudinal Studies | 6 | 2026 | 2949 | 0.450 |
Why?
| | Papillomavirus Vaccines | 1 | 2019 | 296 | 0.440 |
Why?
| | Risk Assessment | 5 | 2019 | 3740 | 0.440 |
Why?
| | Internet | 2 | 2020 | 689 | 0.430 |
Why?
| | Walking | 6 | 2026 | 542 | 0.430 |
Why?
| | Humans | 82 | 2026 | 145140 | 0.430 |
Why?
| | Papillomavirus Infections | 1 | 2019 | 343 | 0.430 |
Why?
| | Advance Care Planning | 4 | 2025 | 244 | 0.410 |
Why?
| | Epilepsies, Myoclonic | 3 | 2018 | 59 | 0.380 |
Why?
| | Data Mining | 1 | 2014 | 113 | 0.380 |
Why?
| | Amputees | 2 | 2026 | 98 | 0.370 |
Why?
| | Female | 57 | 2026 | 78636 | 0.370 |
Why?
| | Treatment Outcome | 9 | 2026 | 11741 | 0.360 |
Why?
| | Osteoarthritis, Knee | 3 | 2025 | 280 | 0.340 |
Why?
| | Renal Dialysis | 2 | 2026 | 466 | 0.340 |
Why?
| | Veterans | 7 | 2025 | 1625 | 0.340 |
Why?
| | Male | 50 | 2026 | 72664 | 0.340 |
Why?
| | Primary Health Care | 5 | 2026 | 1725 | 0.340 |
Why?
| | Epileptic Syndromes | 3 | 2021 | 98 | 0.330 |
Why?
| | Exercise Therapy | 3 | 2025 | 475 | 0.320 |
Why?
| | Family Planning Services | 2 | 2022 | 93 | 0.310 |
Why?
| | Down Syndrome | 3 | 2021 | 525 | 0.310 |
Why?
| | Postoperative Complications | 6 | 2018 | 2961 | 0.300 |
Why?
| | Aged | 28 | 2026 | 26096 | 0.300 |
Why?
| | Recovery of Function | 5 | 2026 | 715 | 0.300 |
Why?
| | Kidney Failure, Chronic | 2 | 2026 | 599 | 0.300 |
Why?
| | Tacrolimus | 2 | 2021 | 195 | 0.290 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1922 | 0.290 |
Why?
| | Contraception | 2 | 2022 | 170 | 0.290 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2928 | 0.280 |
Why?
| | Vision Disorders | 2 | 2021 | 179 | 0.280 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1058 | 0.280 |
Why?
| | Exercise | 3 | 2025 | 2191 | 0.280 |
Why?
| | Biomarkers | 4 | 2021 | 4282 | 0.270 |
Why?
| | Community Health Workers | 2 | 2026 | 88 | 0.260 |
Why?
| | Research Design | 1 | 2013 | 1132 | 0.260 |
Why?
| | Child | 18 | 2025 | 22670 | 0.250 |
Why?
| | Anticonvulsants | 2 | 2022 | 246 | 0.250 |
Why?
| | Middle Aged | 26 | 2026 | 36126 | 0.250 |
Why?
| | Patient Navigation | 2 | 2026 | 126 | 0.250 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2016 | 27 | 0.240 |
Why?
| | Arthroplasty, Replacement, Shoulder | 1 | 2026 | 41 | 0.230 |
Why?
| | Self-Management | 2 | 2025 | 201 | 0.230 |
Why?
| | Developmental Disabilities | 2 | 2019 | 281 | 0.220 |
Why?
| | Retrospective Studies | 18 | 2026 | 17247 | 0.220 |
Why?
| | Electroencephalography | 3 | 2024 | 561 | 0.220 |
Why?
| | Patient Portals | 1 | 2025 | 50 | 0.220 |
Why?
| | Monte Carlo Method | 3 | 2026 | 147 | 0.220 |
Why?
| | Markov Chains | 3 | 2026 | 129 | 0.220 |
Why?
| | Advance Directives | 1 | 2025 | 88 | 0.220 |
Why?
| | Adult | 24 | 2026 | 40665 | 0.210 |
Why?
| | Patient Reported Outcome Measures | 2 | 2026 | 497 | 0.210 |
Why?
| | Quality Improvement | 6 | 2019 | 1293 | 0.200 |
Why?
| | Hospitalization | 4 | 2020 | 2458 | 0.200 |
Why?
| | Lennox Gastaut Syndrome | 2 | 2021 | 19 | 0.200 |
Why?
| | Adipose Tissue, Brown | 1 | 2024 | 60 | 0.200 |
Why?
| | Preoperative Care | 2 | 2016 | 380 | 0.200 |
Why?
| | Renal Insufficiency | 1 | 2025 | 172 | 0.200 |
Why?
| | Ambulatory Care Facilities | 1 | 2026 | 269 | 0.200 |
Why?
| | Task Performance and Analysis | 1 | 2024 | 198 | 0.200 |
Why?
| | Lower Extremity | 2 | 2024 | 440 | 0.190 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 161 | 0.190 |
Why?
| | Postural Balance | 1 | 2026 | 244 | 0.190 |
Why?
| | Surgical Procedures, Operative | 2 | 2016 | 271 | 0.190 |
Why?
| | United States | 17 | 2026 | 16065 | 0.190 |
Why?
| | Group Processes | 2 | 2020 | 63 | 0.180 |
Why?
| | Aged, 80 and over | 11 | 2026 | 8318 | 0.180 |
Why?
| | Artificial Limbs | 1 | 2026 | 203 | 0.180 |
Why?
| | Logistic Models | 4 | 2021 | 2133 | 0.180 |
Why?
| | Proportional Hazards Models | 2 | 2026 | 1325 | 0.180 |
Why?
| | Spasm | 1 | 2022 | 21 | 0.180 |
Why?
| | Cosyntropin | 1 | 2022 | 7 | 0.180 |
Why?
| | Patient Readmission | 2 | 2018 | 769 | 0.180 |
Why?
| | Adolescent | 16 | 2024 | 22479 | 0.180 |
Why?
| | Weight Gain | 1 | 2026 | 561 | 0.180 |
Why?
| | Accidental Falls | 1 | 2024 | 225 | 0.170 |
Why?
| | Hospital Mortality | 2 | 2016 | 1038 | 0.170 |
Why?
| | Computer Simulation | 2 | 2026 | 1002 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 459 | 0.170 |
Why?
| | Kidney Pelvis | 1 | 2021 | 22 | 0.170 |
Why?
| | Activities of Daily Living | 1 | 2024 | 439 | 0.170 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 465 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2026 | 381 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 482 | 0.160 |
Why?
| | Palliative Care | 2 | 2026 | 1017 | 0.160 |
Why?
| | Telemedicine | 3 | 2025 | 956 | 0.160 |
Why?
| | Disease Progression | 4 | 2022 | 2857 | 0.160 |
Why?
| | Ureteral Obstruction | 1 | 2021 | 63 | 0.160 |
Why?
| | Seizures | 1 | 2024 | 482 | 0.150 |
Why?
| | Text Messaging | 1 | 2022 | 182 | 0.150 |
Why?
| | ROC Curve | 1 | 2021 | 617 | 0.150 |
Why?
| | Mobile Applications | 1 | 2022 | 199 | 0.150 |
Why?
| | Resuscitation Orders | 1 | 2020 | 48 | 0.150 |
Why?
| | Emergency Service, Hospital | 2 | 2026 | 2377 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2021 | 227 | 0.150 |
Why?
| | Inpatients | 3 | 2021 | 552 | 0.150 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 837 | 0.150 |
Why?
| | Postnatal Care | 1 | 2019 | 76 | 0.140 |
Why?
| | Sleep | 2 | 2024 | 887 | 0.140 |
Why?
| | Epilepsy | 2 | 2024 | 390 | 0.140 |
Why?
| | Prostatic Neoplasms | 1 | 2026 | 978 | 0.140 |
Why?
| | Age Factors | 6 | 2025 | 3338 | 0.140 |
Why?
| | Medical History Taking | 1 | 2019 | 117 | 0.140 |
Why?
| | Graft Survival | 1 | 2021 | 517 | 0.140 |
Why?
| | Gait | 1 | 2021 | 312 | 0.140 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5886 | 0.140 |
Why?
| | Head and Neck Neoplasms | 1 | 2023 | 561 | 0.140 |
Why?
| | Rural Health Services | 1 | 2019 | 138 | 0.140 |
Why?
| | Hospital Costs | 1 | 2019 | 125 | 0.140 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.140 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 226 | 0.140 |
Why?
| | Child, Preschool | 10 | 2025 | 11835 | 0.130 |
Why?
| | Antibody Formation | 1 | 2019 | 287 | 0.130 |
Why?
| | Young Adult | 9 | 2024 | 14176 | 0.130 |
Why?
| | Automobile Driver Examination | 1 | 2017 | 9 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2019 | 172 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2019 | 160 | 0.130 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 138 | 0.130 |
Why?
| | Community Health Services | 1 | 2019 | 231 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2021 | 437 | 0.130 |
Why?
| | Postoperative Care | 2 | 2017 | 286 | 0.130 |
Why?
| | Symptom Assessment | 1 | 2019 | 136 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1186 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2026 | 1099 | 0.130 |
Why?
| | Thoracoscopy | 1 | 2017 | 60 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2662 | 0.130 |
Why?
| | Mass Screening | 1 | 2026 | 1354 | 0.130 |
Why?
| | Thyrotropin | 1 | 2017 | 120 | 0.130 |
Why?
| | Croup | 1 | 2017 | 19 | 0.130 |
Why?
| | Automobile Driving | 2 | 2016 | 157 | 0.130 |
Why?
| | Caregivers | 1 | 2026 | 1070 | 0.120 |
Why?
| | Hydrocarbons | 1 | 2016 | 29 | 0.120 |
Why?
| | Mental Disorders | 2 | 2016 | 1154 | 0.120 |
Why?
| | Esophagectomy | 1 | 2018 | 135 | 0.120 |
Why?
| | Lung | 3 | 2023 | 4101 | 0.120 |
Why?
| | Time Factors | 5 | 2026 | 7107 | 0.120 |
Why?
| | Patient Participation | 1 | 2020 | 437 | 0.120 |
Why?
| | Construction Industry | 1 | 2016 | 19 | 0.120 |
Why?
| | Infant | 9 | 2024 | 10060 | 0.120 |
Why?
| | Transgender Persons | 1 | 2020 | 210 | 0.120 |
Why?
| | Colorado | 5 | 2026 | 4538 | 0.120 |
Why?
| | Air Pollutants, Occupational | 1 | 2016 | 41 | 0.120 |
Why?
| | Cross Infection | 1 | 2019 | 260 | 0.120 |
Why?
| | Patient Discharge | 3 | 2025 | 991 | 0.120 |
Why?
| | Quality of Life | 2 | 2026 | 3194 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1742 | 0.120 |
Why?
| | Polysomnography | 1 | 2017 | 239 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 946 | 0.120 |
Why?
| | Hormone Replacement Therapy | 1 | 2017 | 107 | 0.120 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 208 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 147 | 0.120 |
Why?
| | Body Composition | 1 | 2020 | 690 | 0.120 |
Why?
| | Tissue Donors | 1 | 2019 | 419 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 167 | 0.120 |
Why?
| | Medicaid | 2 | 2020 | 466 | 0.120 |
Why?
| | Organ Transplantation | 1 | 2019 | 250 | 0.120 |
Why?
| | Health Resources | 1 | 2017 | 130 | 0.110 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 395 | 0.110 |
Why?
| | Heart Arrest | 1 | 2020 | 408 | 0.110 |
Why?
| | Treatment Failure | 1 | 2016 | 360 | 0.110 |
Why?
| | Obesity | 2 | 2019 | 3097 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2020 | 472 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 317 | 0.110 |
Why?
| | Data Collection | 1 | 2017 | 639 | 0.110 |
Why?
| | Ultrasonography | 1 | 2019 | 784 | 0.110 |
Why?
| | Rehabilitation Centers | 1 | 2015 | 39 | 0.110 |
Why?
| | Risk Factors | 6 | 2019 | 10857 | 0.110 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 107 | 0.110 |
Why?
| | Life Change Events | 1 | 2015 | 145 | 0.100 |
Why?
| | Nutrition Surveys | 1 | 2016 | 279 | 0.100 |
Why?
| | Perception | 1 | 2017 | 377 | 0.100 |
Why?
| | Physician-Patient Relations | 2 | 2016 | 587 | 0.100 |
Why?
| | Independent Living | 1 | 2015 | 116 | 0.100 |
Why?
| | Accelerometry | 2 | 2025 | 118 | 0.100 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 543 | 0.100 |
Why?
| | Vaccines | 1 | 2019 | 388 | 0.100 |
Why?
| | Poisson Distribution | 1 | 2013 | 78 | 0.100 |
Why?
| | Patient Admission | 1 | 2016 | 220 | 0.100 |
Why?
| | Esophageal Neoplasms | 1 | 2018 | 345 | 0.100 |
Why?
| | Hospitals | 2 | 2016 | 732 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 435 | 0.100 |
Why?
| | Testosterone | 1 | 2017 | 415 | 0.100 |
Why?
| | Physician's Role | 1 | 2015 | 222 | 0.100 |
Why?
| | General Surgery | 1 | 2016 | 206 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2014 | 191 | 0.100 |
Why?
| | Insurance, Health | 1 | 2016 | 310 | 0.100 |
Why?
| | Cognition | 2 | 2025 | 1262 | 0.100 |
Why?
| | Nursing Homes | 1 | 2015 | 173 | 0.090 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 302 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2019 | 710 | 0.090 |
Why?
| | Occupational Exposure | 1 | 2016 | 355 | 0.090 |
Why?
| | Parents | 2 | 2021 | 1401 | 0.090 |
Why?
| | Walk Test | 2 | 2023 | 81 | 0.090 |
Why?
| | Cluster Analysis | 1 | 2014 | 500 | 0.090 |
Why?
| | Prospective Studies | 2 | 2022 | 8035 | 0.090 |
Why?
| | Databases, Factual | 4 | 2018 | 1488 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1244 | 0.080 |
Why?
| | Cohort Studies | 5 | 2021 | 5988 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2016 | 577 | 0.080 |
Why?
| | Body Mass Index | 1 | 2020 | 2437 | 0.080 |
Why?
| | Histones | 1 | 2016 | 665 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2016 | 608 | 0.080 |
Why?
| | Single-Blind Method | 2 | 2021 | 316 | 0.080 |
Why?
| | Surveys and Questionnaires | 3 | 2018 | 6055 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2014 | 784 | 0.080 |
Why?
| | Length of Stay | 4 | 2018 | 1348 | 0.080 |
Why?
| | Recurrence | 1 | 2013 | 1134 | 0.080 |
Why?
| | Vaccination | 1 | 2019 | 1423 | 0.080 |
Why?
| | Child Abuse | 1 | 2015 | 552 | 0.070 |
Why?
| | Pregnancy Complications | 1 | 2015 | 600 | 0.070 |
Why?
| | Influenza Vaccines | 1 | 2014 | 534 | 0.070 |
Why?
| | Preventive Health Services | 2 | 2020 | 153 | 0.070 |
Why?
| | Postoperative Period | 2 | 2021 | 351 | 0.070 |
Why?
| | Sex Factors | 3 | 2020 | 2099 | 0.070 |
Why?
| | Guatemala | 2 | 2019 | 343 | 0.070 |
Why?
| | Brain Concussion | 1 | 2016 | 640 | 0.070 |
Why?
| | Comorbidity | 3 | 2017 | 1657 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 2183 | 0.070 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2017 | 22 | 0.070 |
Why?
| | Minimal Clinically Important Difference | 1 | 2026 | 31 | 0.060 |
Why?
| | Morbidity | 2 | 2019 | 322 | 0.060 |
Why?
| | Mothers | 2 | 2022 | 764 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1993 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2324 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 1109 | 0.050 |
Why?
| | Survival Rate | 2 | 2020 | 2087 | 0.050 |
Why?
| | Prognosis | 2 | 2026 | 4310 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2026 | 310 | 0.050 |
Why?
| | Pilot Projects | 2 | 2020 | 1889 | 0.050 |
Why?
| | Equivalence Trials as Topic | 1 | 2024 | 35 | 0.050 |
Why?
| | Femur | 1 | 2026 | 254 | 0.050 |
Why?
| | Habits | 1 | 2024 | 52 | 0.050 |
Why?
| | Thermogenesis | 1 | 2024 | 45 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2026 | 419 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 410 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2026 | 354 | 0.050 |
Why?
| | Epilepsies, Partial | 1 | 2024 | 63 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 217 | 0.050 |
Why?
| | Wakefulness | 1 | 2024 | 170 | 0.050 |
Why?
| | Survival Analysis | 1 | 2026 | 1371 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 206 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 216 | 0.050 |
Why?
| | Language | 1 | 2025 | 322 | 0.050 |
Why?
| | Pseudomonas | 1 | 2022 | 30 | 0.050 |
Why?
| | Vulnerable Populations | 1 | 2023 | 175 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 343 | 0.040 |
Why?
| | Cotinine | 1 | 2021 | 76 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 367 | 0.040 |
Why?
| | Socioeconomic Factors | 2 | 2016 | 1321 | 0.040 |
Why?
| | Hydronephrosis | 1 | 2021 | 36 | 0.040 |
Why?
| | Pregnancy | 3 | 2019 | 7182 | 0.040 |
Why?
| | Smoking Prevention | 1 | 2021 | 166 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2020 | 1188 | 0.040 |
Why?
| | Quadriceps Muscle | 1 | 2021 | 120 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 138 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 134 | 0.040 |
Why?
| | Milk, Human | 1 | 2022 | 174 | 0.040 |
Why?
| | Urologic Surgical Procedures | 1 | 2021 | 115 | 0.040 |
Why?
| | Home Health Nursing | 1 | 2019 | 13 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2020 | 141 | 0.040 |
Why?
| | Postpartum Period | 1 | 2022 | 372 | 0.040 |
Why?
| | Reproductive Health | 1 | 2019 | 91 | 0.040 |
Why?
| | Health Behavior | 1 | 2024 | 787 | 0.040 |
Why?
| | Muscle Strength | 1 | 2021 | 332 | 0.040 |
Why?
| | Glucose | 1 | 2024 | 1048 | 0.030 |
Why?
| | Breast Feeding | 1 | 2022 | 446 | 0.030 |
Why?
| | Documentation | 1 | 2020 | 199 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5411 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2021 | 856 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2019 | 129 | 0.030 |
Why?
| | Peer Group | 1 | 2020 | 252 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 527 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2024 | 933 | 0.030 |
Why?
| | House Calls | 1 | 2019 | 154 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.030 |
Why?
| | Snoring | 1 | 2017 | 19 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2019 | 367 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 179 | 0.030 |
Why?
| | Perioperative Period | 1 | 2017 | 70 | 0.030 |
Why?
| | Mentoring | 1 | 2020 | 165 | 0.030 |
Why?
| | Women's Health | 1 | 2019 | 314 | 0.030 |
Why?
| | Pandemics | 1 | 2025 | 1703 | 0.030 |
Why?
| | Cesarean Section | 1 | 2019 | 229 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2016 | 25 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2019 | 188 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 179 | 0.030 |
Why?
| | Oximetry | 1 | 2017 | 125 | 0.030 |
Why?
| | Body Height | 1 | 2017 | 201 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2020 | 336 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 492 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 4071 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 640 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 556 | 0.030 |
Why?
| | Housing for the Elderly | 1 | 2015 | 7 | 0.030 |
Why?
| | Financing, Personal | 1 | 2015 | 27 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 644 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 290 | 0.030 |
Why?
| | Health Surveys | 1 | 2017 | 517 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 220 | 0.030 |
Why?
| | Probability | 1 | 2016 | 307 | 0.030 |
Why?
| | Risk | 1 | 2017 | 916 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 902 | 0.030 |
Why?
| | Lymphocytes | 1 | 2016 | 376 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 149 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2016 | 450 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1470 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2016 | 238 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 2017 | 286 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2016 | 346 | 0.030 |
Why?
| | Rural Population | 1 | 2019 | 657 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2016 | 368 | 0.030 |
Why?
| | Depression | 1 | 2023 | 1537 | 0.030 |
Why?
| | Health Services Research | 1 | 2016 | 391 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 881 | 0.020 |
Why?
| | Weight Loss | 1 | 2019 | 845 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2016 | 336 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2015 | 535 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2115 | 0.020 |
Why?
| | Life Style | 1 | 2016 | 483 | 0.020 |
Why?
| | Body Weight | 1 | 2017 | 969 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1995 | 0.020 |
Why?
| | Disease Management | 1 | 2017 | 651 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3616 | 0.020 |
Why?
| | Oxygen | 1 | 2017 | 978 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 557 | 0.020 |
Why?
| | Surgeons | 1 | 2016 | 340 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2016 | 539 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1134 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2017 | 924 | 0.020 |
Why?
| | Registries | 1 | 2020 | 2401 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3410 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6435 | 0.020 |
Why?
|
|
Juarez-Colunga's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|